LFG
LEGN icon

Larson Financial Group’s Legend Biotech LEGN Stock Holding History

Larson Financial Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85K Buy
+64
New +$1.73K ﹤0.01% 3143
2025
Q4 		– Sell
-2
Closed -$65 – 3582
2025
Q3 		$65 Buy
+2
New +$74 ﹤0.01% 3343

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Larson Financial Group's LEGN Position: Q2 2026 in Review

Larson Financial Group opened a new position in Legend Biotech (LEGN) in Q2 2026: 64 shares worth $1.85K. The stake represents ﹤0.01% of the portfolio and ranks #3143 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in LEGN as recently as Q3 2025.

Larson Financial Group first reported a position in LEGN in Q3 2025 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Larson Financial Group held 64 shares of Legend Biotech worth $1.85K as of Q2 2026.
  • Legend Biotech was a new Larson Financial Group position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3143 holding.
  • Larson Financial Group first reported a position in Legend Biotech in Q3 2025 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.